To determine whether the induction of these cytokines depended on either tumor or immune cell STING expression, cytokine responses were evaluated in the serum and tumors from both WT and STING-deficient mice bearing WT or STING-deficient B16F10 tumors following treatment with TAK-676. Here, STING1 is linked to neoplasm.